Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Abrikosov's Tumor
Welcome,
Profile
Billing
Logout
2 Companies
1 Product
1 Product
0 Mechanisms of Action
0 Trials
6 News
||||||||||
orteronel
(TAK 700) /
Takeda
Enrollment change, Trial termination, Metastases:
Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
(clinicaltrials.gov) - Mar 1, 2017
P2
, N=10, Terminated,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
N=20 --> 10 | Recruiting --> Terminated; Slow recruitment rate
||||||||||
ketoconazole
/
Generic mfg.
Enrollment change, Trial termination, Trial primary completion date, Metastases:
GreKo: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
(clinicaltrials.gov) - Jan 22, 2015
P2
, N=6, Terminated,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
N=20 --> 10 | Recruiting --> Terminated; Slow recruitment rate N=17 --> 6 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Nov 2014; Insufficient recruitment rate
|
|||||||||
orteronel
(TAK 700) /
Takeda
Enrollment open, Metastases:
Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
(clinicaltrials.gov) - Jul 17, 2014
P2
, N=20, Recruiting,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
N=17 --> 6 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Nov 2014; Insufficient recruitment rate Not yet recruiting --> Recruiting
|
|||||||||
orteronel
(TAK 700) /
Takeda
New P2 trial, Metastases:
Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
(clinicaltrials.gov) - Mar 31, 2014
P2
, N=20, Not yet recruiting,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
||||||||||
ketoconazole
/
Generic mfg.
Enrollment open, Metastases:
GreKo: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
(clinicaltrials.gov) - Dec 11, 2012
P2
, N=17, Recruiting,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
||||||||||
ketoconazole
/
Generic mfg.
New P2 trial, Metastases:
GreKo: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
(clinicaltrials.gov) - Apr 22, 2012
P2
, N=17, Recruiting,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes